One of our most popular market reports is “Stem Cell Research Products – Opportunities, Tools, & Technologies.” It is a 175-page global strategic report that tracks traditional market metrics, which include trend rate data for stem cell clinical trials, scientific publications, grants, patents, product launches, new market entrants, acquisitions, industry deal-making, and more.
Importantly, it also tracks recently discovered social analytics, which are metrics derived from social media sites, search engines, online advertising platforms, and more. Specifically, social analytics can be collected from platforms like Twitter, LinkedIn, Facebook, Google Search, and Google Trends.
The importance of these social analytics is that they reveal both individual user behavior on a topic, as well as aggregate group activity.
You can use them to discover the frequency at which online users are searching for, posting about, and seeking stem cell product information.
In my experience, you need these social analytics to make profitable marketing and product development decisions.
Finally, a distinctive feature of this report is an end-user survey of nearly 300 stem cell researchers worldwide.
It can be difficult to get into the mind of stem cell scientists, so these survey findings reveal current needs, technical preferences, key factors influencing buying decisions, and much more.
Invest in “Stem Cell Research Products – Opportunities, Tools, & Technologies” now, because your level of income will rarely exceed your level of knowledge.
BioInformant is the first and only market research firm to specialize exclusively in the stem cell industry. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, Medical Ethics, Vogue Magazine, and more. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.